Fucidin tablet: Out of specification
Brand(s)
Last updated
Summary
Product
Fucidin tablet 250mg
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Leo Pharma | Fucidin tablet | N/A (Special Access Program drug) | Tablet | Sodium Fusidate 250mg | C97100 |
Issue
Out of specification result obtained for affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Leo Pharma Inc.
6 Adelaide Street East, Suite 200
Toronto, ON
M5C 1H6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-77778
Get notified
Receive notifications for new and updated recalls and alerts by category.